Asymchem Laboratories (Tianjin) logo

Asymchem Laboratories (Tianjin)

Asia, Guangdong, China, Tianjin

Description

Asymchem Laboratories (Tianjin) is focused on the R&D of the pharmaceutical raw materials synthesis technology and more.

Investor Profile

Asymchem Laboratories (Tianjin) has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Life Science.

Stage Focus

  • Series A (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Asymchem Laboratories (Tianjin) frequently co-invest with?

Haiwang Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
CC
Asia, Liaoning, China, Chaoyang
Co-Investments: 1
Sino Biological
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Asymchem Laboratories (Tianjin)?

Bio-Link

Shanghai, Shanghai, China

Bio-Link is a drug development company that offers solutions for the life science industry.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series AFeb 21, 2024